Abstract-Prolonged ischemia increases cytosolic Ca 2ϩ concentration in cardiomyocytes. Cells with severely elevated cytosolic Ca 2ϩ may respond to reperfusion, developing hypercontracture, sarcolemmal disruption, and death. Cardiomyocytes are efficiently connected through gap junctions (GJs) to form a functional syncytium, and it has been shown that hypercontracture can be propagated to adjacent myocytes through a GJ-mediated mechanism. This study investigated the mechanism of propagation of cell injury associated with sarcolemmal rupture in end-to-end connected pairs of isolated rat cardiomyocytes. Microinjection of extracellular medium into one of the cells to simulate sarcolemmal disruption induced a marked increase in cytosolic Ca 2ϩ (fura-2) and Na ϩ (SBFI) in the adjacent cell and its hypercontracture in Ͻ30 seconds (22 of 22 cell pairs). This process was not modified when Ca 2ϩ release from the sarcoplasmic reticulum was blocked with 10 mol/L ryanodine (5 of 5 cell pairs), but it was fully dependent on the presence of Ca 2ϩ in the extracellular buffer. Blockade of L-type Ca 2ϩ channels with 10 mol/L nifedipine did not alter propagation of hypercontracture. However, the presence of 15 to 20 mol/L KB-R7943, a highly selective blocker of reverse Na ϩ /Ca 2ϩ exchange, prevented propagation of hypercontracture in 16 of 20 cell pairs (PϽ0.01) without interfering with GJ permeability, as assessed by the Lucifer Yellow transfer method. Addition of the Ca 2ϩ chelator EGTA (2 mmol/L) to the injection solution prevented hypercontracture in the injected cell but not in the adjacent one (nϭ5). These results indicate that passage of Na ϩ through GJ from hypercontracting myocytes with ruptured sarcolemma to adjacent cells, and secondary entry of [Ca 2ϩ ] o via reverse Na ϩ /Ca 2ϩ exchange, can contribute to cell-to-cell propagation of hypercontracture. This previously unrecognized mechanism could increase myocardial necrosis during ischemia-reperfusion in vivo and be the target of new treatments aimed to limit it. (Circ Res. 1999;85:280-287.)
G ap junctions (GJs) play an essential role in the normal function of the cardiovascular system; they mediate the spread of electrical impulses that stimulate synchronized contraction of the cardiac muscle and coordinate the function of endothelial and smooth muscle cells in arterial walls. 1, 2 GJ-mediated communication is also essential for normal embryonic development as well as for the function of many other adult organs, including the lungs, retina, lens, liver, and central nervous system. [3] [4] [5] Recent studies have demonstrated that neuron GJs remain open during brain ischemia, therefore linking dying cells with potentially viable ones, and that cerebral infarcts may expand over time by a GJ-mediated mechanism. 6 The extent of ischemic injury can be significantly decreased when GJ permeability is reduced with octanol. 7 However, the role of GJs in chemical communication of cardiac muscle cells, and in particular their possible involvement in cell death secondary to ischemia-reperfusion, is poorly understood. After an ischemic episode, cardiomyocytes may respond to reenergization by developing an abrupt and extreme distortion of their architecture, resulting from development of excessive contractile force. 8 This phenomenon, named hypercontracture, causes extreme cell shortening and may occur during the first minutes of reflow as the consequence of ATP availability in the presence of abnormally high [Ca 2ϩ ] i concentration and cytoskeletal fragility caused by ischemia. 9, 10 Reperfused myocardial infarcts consist almost exclusively of areas of contraction band necrosis formed by hypercontracted dead myocytes. 11 A striking feature of these areas of necrosis is that they usually contain hypercontracted cardiomyocytes in compact clusters, with highly indented and irregular borders or even a patchy appearance, whereas hypercontracted cardiomyocytes in scattered distribution are virtually absent. 12 Gradients in wall tension, collateral flow and concentration of catabolites, and diffusion of O 2 from endocardial and epicardial surfaces or nonischemic myocardium may influence the regional distribution of the areas of necrosis but cannot explain the continuity of these areas and the absence of scattered hypercontracted myocytes. Studies using computer simulation of infarct morphology demonstrate that some kind of cell-to-cell interaction must be taken into account to reproduce these features of infarct geometry. 13 In a recent study, we found that the GJ blocker heptanol, applied only at the time of reenergization, was able to reduce the final extent of myocardial necrosis and to alter infarct geometry in intact rat and pig hearts. At the cellular level, we observed that hypercontracture of a myocyte was consistently propagated to the adjacent cell and that chemical uncoupling with heptanol prevented this spreading of cell injury. Moreover, these effects of heptanol were observed at concentrations that did not afford any protection against reoxygenation-induced hypercontracture in single cells. 14 These studies strongly support the hypothesis that the fate of a cardiomyocyte after an ischemic period is not only determined by its own biochemical derangements but may also be influenced by the survival or death of adjacent cells.
There is ample evidence that, in contrast to what happens in isolated cardiomyocytes, in myocardial tissue hypercontracture is associated with sarcolemmal rupture and enzyme release. 15 Sarcolemmal disruption causes dramatic changes in cytosolic composition that can be propagated to adjacent cells through GJs and result in cell-to-cell propagation of hypercontracture. The present study was aimed at identifying the chemical messenger responsible for this cell-to-cell propagation of hypercontracture through GJs. Hypercontracture of freshly isolated adult rat cardiomyocytes was induced by microinjection of extracellular media containing 1 mmol/L Ca 2ϩ to simulate sarcolemmal disruption, and its propagation between end-to-end connected cell pairs was analyzed under different interventions.
Materials and Methods

Cardiomyocyte Isolation Procedure
Animals were handled according to the Declaration of Helsinki, and the experimental procedures were approved by the Research Commission of the Hospital Vall d'Hebron. Ventricular heart muscle cells were isolated from adult male Sprague-Dawley rats (300 g) as previously described. 16 Briefly, whole hearts were retrogradely perfused in a Langendorff system with a modified Krebs buffer (in mmol/L, NaCl 110, KCl 2.6, KH 2 PO 4 1.2, MgSO 4 1.2, NaHCO 3 25, and glucose 11) containing 45 mol/L CaCl 2 and 0.03% collagenase (type II, Serva). Cells from dissociated tissue were subjected to a progressive normalization of Ca 2ϩ levels to a final concentration of 1 mmol/L. Rod-shaped cells were selected by gravity sedimentation in a 4% BSA gradient (fraction V, Boehringer Mannheim) and plated in glass-bottomed dishes with medium 199/HEPES (Sigma) and 4% FCS (Gibco). Two hours after plating, broken nonattached cells were discarded by changing the medium. Five to ten end-to-end-connected myocytes were found in each culture dish, and propagation of hypercontracture between adjacent cells, GJ permeability, and changes in intracellular Na ϩ and Ca 2ϩ concentrations were studied in these cell pairs.
Microinjection and Experimental Conditions
One of the cells of each pair was microinjected with extracellular medium to simulate sarcolemmal disruption occurring during reoxygenation-induced hypercontracture. A hydraulic micromanipulator with digital control (digital micromanipulator model 5171 and transjector model 5246, Eppendorf) was used. Microinjection was performed through a 0.2-to 0.5-m-tip sterile micropipette (Sterile Femtotips, Eppendorf) by a pulse pressure of 400 hPa of 0.1-second duration. The axial and depth limits were set to allow penetration of the micropipette 3 to 5 m below cell surface at an angle of 45°. Previous studies using the same micropipettes and similar solutions showed that these microinjection parameters allow effective injection without detectable mechanical injury. 17 In control experiments, the extracellular medium was a buffer containing (in mmol/L) NaCl 140, KCl 3.6, MgSO 4 1.2, CaCl 2 1, and HEPES 20. The modifications of the extracellular buffer included the addition of (1) 10 mol/L ryanodine, (2) 10 mol/L nifedipine, or (3) 15 mol/L and 20 mol/L KB-R7943, or the replacement of Ca 2ϩ by 2 mmol/L EGTA. The microinjected solution was modified in some experiments by replacing Ca 2ϩ by 2 mmol/L EGTA. To assess GJ permeability, 2% Lucifer Yellow was added to the microinjection solution in a series of experiments. All experiments were performed at 37°C (Digital Warm Stage Controller, Linkam) on the stage of an inverted microscope (Olympus IMT-2). Cell images were continuously videorecorded at ϫ400 magnifications. Relative changes in cell length were measured on the videorecorded images. Measurements were performed in both cells every 2 seconds during the first 30 seconds after microinjection, except when indicated otherwise. Transfer dye through GJs was monitored under fluorescent microscopy using a 420-nm excitation light with a bandwidth of 15 nm.
Measurement of [Ca 2؉ ] i and Na ؉ Concentrations
Ratiofluorescence studies were performed in a separate series of experiments under the previously described conditions. Changes in [Ca 2ϩ ] i and Na ϩ concentrations were analyzed in myocytes loaded with fura-2 or SBFI (Molecular Probes), respectively. For loading, cells were incubated for 30 minutes at 37°C in medium 199 with the acetoxymethyl ester of fura-2 (5 mol/L) or SBFI (10 mol/L). Myocytes were then washed twice and postincubated for 20 minutes in medium 199 to allow hydrolysis of the acetoxymethyl esters within the cells. Petri dishes with fura-2 or SBFI-loaded myocytes were positioned on the temperature-controlled stage of an inverted fluorescent microscope (Olympus IX70) with a fluorite objective (UplaFL ϫ200 or ϫ400, Olympus). Ratiofluorescence measurements were performed by a commercially available imaging system (QuantiCell 900, Applied Imaging). Cells were alternatively excited at 340 and 380 nm, with a bandwidth of 15 nm, by means of a fast-speed monochromator. Exposure time was set for each excitation wavelength according to fluorescence intensity and was typically 40 to 80 ms. Emitted light was collected by an air-cooled intensified digital camera with a resolution of 640ϫ640 pixels. Counts from clusters of 2ϫ2 or 4ϫ4 pixels were pooled to use shorter exposure times and to improve signal/noise ratio. Ratios of 340/380 were calculated for each pixel cluster from signal intensities in that cluster in pairs of images consecutively obtained at the 2 wavelengths, and color-coded 340/380 ratio images were generated. The average ratio was calculated for regions of interest defined in these images, and the changes in these average ratio values through time were analyzed.
Field Stimulation of Cardiomyocytes
To assess the potential effects of KB-R7943 on cytosolic Ca 2ϩ transients and contractility, changes in cell length and ratiofluorescence were analyzed in cardiomyocytes submitted to field stimulation at 1 Hz, as previously described. 18 Biphasic electrical pacing composed of 2 equal but opposed rectangular 40-V stimuli of 0.5-ms duration were applied between 2 silver electrodes immersed in the fluid. Measurements were performed before addition of any drug to the extracellular fluid and after addition of KB-R7943 at 15 mol/L.
Results
Role of [Ca 2؉ ] o in the Propagation of Hypercontracture
In control conditions (extracellular and microinjected solutions composed of HEPES buffer with ionic composition mimicking physiological extracellular media), microinjection of extracellular buffer consistently induced hypercontracture of the injected myocyte, and the rapid rise in cytosolic Ca 2ϩ concentration in the microinjected cell was followed within a few seconds by a similar rise in the adjacent cell and by its hypercontracture (Figure 1) . However, when Ca 2ϩ was replaced in the extracellular medium by the Ca 2ϩ chelator EGTA, but not in the injected buffer, the rise in Ca 2ϩ concentration and hypercontracture observed in the injected myocyte were not propagated to the adjacent cell in 16 of 18 cell pairs (Figure 2) . Failure of propagation of hypercontracture in the absence of [Ca 2ϩ ] o was not due to reduced GJ permeability, because transfer of the GJ-permeant dye Lucifer Yellow from the microinjected to the adjacent cell was not modified in the absence of [Ca 2ϩ ] o (Figure 2 ). On the basis of the observed role of [Ca 2ϩ ] o in propagation of hypercontracture, we investigated L-type Ca 2ϩ channels as a likely route of Ca 2ϩ entry into the adjacent cell. However, this possibility was ruled out by repeating the microinjection in the presence of 10 mol/L of the channel blocker nifedipine. Blockade of L-type Ca 2ϩ channels did not modify either Ca 2ϩ rise in the adjacent cell or propagation of hypercontracture ( Figure 2) . Ca 2ϩ release from the sarcoplasmic reticulum (SR) had no effect on cell propagation of hypercontracture. Addition of ryanodine to the extracellular medium (10 mol/L for 15 minutes) did not prevent Ca 2ϩ rise or hypercontracture in the adjacent cell (Figure 2 ).
Passage of Na
؉ and Role of Reverse Na ؉ /Ca 2؉ Exchange
We used ratiofluorescence imaging of cells loaded with the Na ϩ indicator SBFI to demonstrate a rapid and almost simultaneous increase in cytosolic Na ϩ concentration in the microinjected and the adjacent cell (Figure 3) . To determine the role of reverse Na ϩ /Ca 2ϩ exchange in the increase of [Ca 2ϩ ] i concentration and hypercontracture of the adjacent cell, microinjection of extracellular medium was performed in the presence of the novel isothiourea derivative KB-R7943, a highly selective blocker of Na ϩ /Ca 2ϩ exchange in its reverse ] i induced by microinjection in both cells. Change in ratio (‚) at a given time is defined as the value measured at that time divided by the initial value measured before microinjection. Data are meanϮSEM.
mode. 19, 20 Addition of 20 mol/L of KB-R7943 to the extracellular medium prevented propagation of hypercontracture in 12 of 15 cell pairs and markedly delayed it in the remaining 3 ( Figure 3) . A similar effect was observed at 15 mol/L (propagation was observed only in 1 of 5 cell pairs). However, at 10 mol/L of KB-R7943, propagation was observed in 12 of 13 cell pairs, although it was significantly delayed (after 30 seconds of microinjection, hypercontracture was propagated in only 6 of 13 cell pairs). KB-R7943 at 15 mol/L had no influence on either cell shortening (10.3Ϯ0.4% and 10.0Ϯ0.5%, respectively, in the presence and the absence of the drug) or Ca 2ϩ transients induced by field stimulation (Figure 4) . Despite the absence of propagation of hypercontracture, KB-R7943 at 20 mol/L did not alter GJ permeability, as assessed by cell-to-cell diffusion of Lucifer Yellow (Figure 3) .
The role of passage of Na ϩ through GJ and subsequent exchange with [Ca 2ϩ ] o in cell-to-cell propagation of hypercontracture was further tested in a series of experiments in which Ca 2ϩ was replaced by 2 mmol/L EGTA in the microinjection buffer. This consistently resulted in hypercontracture of the adjacent cell despite the absence of any change in length in the microinjected cell ( Figure 3 ) and clearly ruled out the mechanical distortion of GJs as the main cause of propagation of hypercontracture. The fact that the hypercontracture in the adjacent cell is delayed in these experiments may indicate that passage of Ca 2ϩ from the primarily injured cell can contribute to hypercontracture of the adjacent cell. ] i concentration and hypercontracture of the adjacent cell was ruled out in experiments in which hypercontracture was induced in control extracellular buffer containing 10 mol/L ryanodine. This blocker of Ca 2ϩ release from the SR had no effect on Ca 2ϩ rise or hypercontracture (Figure 2) . These results also demonstrate that rapid and important increases in cytosolic Ca 2ϩ concentration associated with sarcolemmal rupture do not result in GJ closure rapid enough to prevent propagation of cell injury.
Transmission of cAMP, IP 3 , or Ca 2ϩ has been involved in cell-to-cell signaling in many cell types, including cardiomyocytes. [21] [22] [23] [24] [25] It could be expected that direct passage of Ca 2ϩ through GJs without the need of Ca 2ϩ entry from the extracellular space could suffice for cell-to-cell propagation of hypercontracture. Our results demonstrate that this is not the case. A possible explanation is that GJ permeability is closely regulated by [Ca 2ϩ ] i concentration. 26 Previous studies have shown that GJs have a low ability to transmit Ca 2ϩ , 27,28 and GJ closure caused by exposure to extracellular levels of Ca 2ϩ could prevent passage of sufficient Ca 2ϩ ions as to induce hypercontracture in the adjacent cell. Transfer of Na ϩ ions, because of the large gradient in cytosolic Na ϩ concentration between the microinjected and the adjacent cell, may allow Ca 2ϩ influx into the second cell through the reverse Na ϩ /Ca 2ϩ exchange after GJ closure. GJs have been shown to allow efficient equalization of cytosolic Na ϩ concentration in other cell types. 29 The observation that passage of Na ϩ through GJs can propagate hypercontracture to adjacent cardiomyocytes may have important implications. There is strong evidence that during myocardial reperfusion, hypercontracture is often associated with sarcolemmal disruption 8 because of the effect of excessive mechanical stress on a membrane with reduced mechanical resistance. 16 Membrane disruption allows influx of extracellular medium with high Na ϩ concentration into the hypercontracting cell, a situation mimicked by microinjection of extracellular medium. Although GJs may be closed during ischemia, they are expected to reopen rapidly in response to oxidative metabolism. The proposed mechanism of cell-tocell propagation of hypercontracture may be thus operative during myocardial reperfusion in vivo. The fact that cell-tocell propagation of hypercontracture depends on sarcolemmal rupture could impose a limit and explain why it does not progress to the whole heart. Cells exposed to less severe ischemia, as those receiving collateral flow, could withstand hypercontracture without developing sarcolemmal rupture and Na ϩ overload. If the amount of Na ϩ is not enough to promote exchange in the reverse mode, propagation would be interrupted.
The sarcolemmal Na ϩ /Ca 2ϩ exchanger is a major regulator of [Ca 2ϩ ] i homeostasis in excitable cells. 30 In most mammalian cardiac muscle cells, the exchanger works mainly in the forward mode, ie, as rapid extruder for Ca 2ϩ that has entered the cardiomyocyte via the sarcolemmal L-type Ca 2ϩ channels to trigger the release of Ca 2ϩ from the SR. Available evidence suggests that in heart, the exchanger competes for Ca 2ϩ with the SR Ca-ATPase to bring about relaxation to a degree dependent on species, developmental stage, and/or physiological state of the heart. However, under pathological conditions such as ischemia-reperfusion injury, the direction of its electrogenic exchange can be changed, and the exchanger is thought to cause Ca 2ϩ overload because of an ischemiadependent increase in Na ϩ . 31 Ca 2ϩ influx through reverse Na ϩ /Ca 2ϩ exchange may suffice to induce contraction when intentionally driven into that mode of action. 32 In our study, addition of the reverse Na ϩ /Ca 2ϩ exchange inhibitor KB-R7943 prevented propagation of hypercontracture in most cases at concentrations of 15 mol/L or greater. KB-R7943 has been shown to act as a potent blocker of reverse Na ϩ /Ca 2ϩ exchange in rat cardiomyocytes (90% inhibition at 10 mol/L) without significant effects on other ion transporters or channels at concentrations Ͻ30 mol/L. At 30 mol/L, KB-R7943 inhibited the dihydropyridine-sensitive Ca 2ϩ uptake by 35% and forward Na ϩ /Ca 2ϩ exchange by 38% without significant influence on Na ϩ /H ϩ exchange, sarcolemmal or SR Ca 2ϩ ATPase, or Na ϩ /K ϩ ATPase activities. 19, 20 In our study, the concentration of KB-R7943 that effectively prevented propagation of hypercontracture had no significant effect on Ca 2ϩ transients or systolic cell shortening of isolated myocytes submitted to field stimulation. KB-R7943 also slowed hypercontracture of the microinjected cell, which suggests that the reverse mode of Na ϩ /Ca 2ϩ exchange represents one of the routes of Ca 2ϩ entry in myocytes primarily injured with microinjection.
The role of passage of Na ϩ through GJs and subsequent exchange with [Ca 2ϩ ] o in cell-to-cell propagation of hypercontracture was further confirmed when Ca 2ϩ was replaced by EGTA in the microinjection buffer. This consistently resulted in hypercontracture of the adjacent cell, at a slower rate than in control conditions, despite the absence of any change in length in the microinjected cell (Figure 3 ). This result constitutes direct evidence that propagation of hypercontracture may occur independently of any physical distortion of GJs secondary to mechanical forces imposed by hypercontracture on intercalated discs. However, a possible role of mechanical interaction in sarcolemmal disruption occurring during hypercontracture cannot be excluded, as was previously suggested. 33, 34 In previous studies injection of EGTA in one cell has not been found to reduce cytosolic Ca 2ϩ concentration in adjacent, GJ-connected cells, which indicates that EGTA does not significantly diffuse through GJs. 27 The slower rate of hypercontracture in the second cell in these experiments could suggest that direct passage of Ca 2ϩ through
GJs, although not sufficient to induce hypercontracture of the second cell, may contribute to its development. The results presented here encourage the study of other potential deleterious effects of GJ-mediated chemical communication in other multicellular systems. Harmful chemical exchange in tissues with well-developed cell-to-cell communication, such as liver or central nervous system, could represent a more generalized mechanism associated with ischemia or hypoxia. In myocardial tissue, cell-to-cell propagation of hypercontracture due to the passage of Na ϩ through GJs could represent a previously unrecognized mechanism of cell death secondary to ischemia-reperfusion. This mechanism could allow propagation of hypercontracture of severely injured cells to other cells with milder ischemic injury that could have otherwise survived. Considering that myocytes are connected to multiple cells through GJs, even a small probability of cell-to-cell progression of hypercontracture could have a major impact in infarct size. Under experimental conditions, drugs decreasing GJ permeability, such as heptanol or octanol, have successfully reduced transmission of potentially harmful metabolic signals in different cell types. 7, 14, 35 Their clinical application is, however, limited by their effects on myocardial contractile function and their arrhythmogenic properties. This study describes a mechanism of cell injury propagation through GJs that could be the target of a very selective intervention without major effects on GJ permeability or ion homeostasis in normal cells.
